The Innovative Health Initiative (IHI) is set to put €2.4 billion into collaborative health research projects between industry, academics and SMEs starting this June. With the launch of IHI, the brief is expanded beyond pharmaceuticals to include biotechnology, medical technology, diagnostics and digital health. Projects will focus on translation of research from Europe’s academic base into health products and services that are designed from the start to meet to public health needs and to be suitable for use in Europe’s healthcare systems. The topics for research in the first year of IHI are expected to be published in April, with the first calls around mid-June, and deadlines at the end of September.